Showing results (231-240 of 242) with videos related to

Sort By:
Pageof 25
British Journal of Clinical Pharmacology|October 4, 2018
Special considerations for clinical trials in fibrodysplasia ossificans progressiva (FOP)Edward C Hsiao, Maja Di Rocco, Amanda Cali, et al.
Plos One|March 15, 2016
Axial Spondylometaphyseal Dysplasia Is Caused by C21orf2 MutationsZheng Wang, Aritoshi Iida, Noriko Miyake, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 25, 2015
Comprehensive genetic exploration of skeletal dysplasia using targeted exome sequencingJun-Seok Bae, Nayoung K D Kim, Chung Lee, et al.
American Journal of Human Genetics|December 14, 2011
Whole-exome sequencing identifies mutations of KIF22 in spondyloepimetaphyseal dysplasia with joint laxity, leptodactylic typeByung-Joo Min, Namshin Kim, Taesu Chung, et al.
Blood|June 11, 2021
Somatic uniparental disomy mitigates the most damaging EFL1 allele combination in Shwachman-Diamond syndromeSangmoon Lee, Chang Hoon Shin, Jawon Lee, et al.
Expert Opinion on Pharmacotherapy|January 21, 2025
Palovarotene in fibrodysplasia ossificans progressiva: review and perspectiveVincent A Verheij, Robert J Diecidue, Esmée Botman, et al.
American Journal of Medical Genetics. Part A|October 4, 2011
Revisit of multiple epiphyseal dysplasia: ethnic difference in genotypes and comparison of radiographic features linked to the COMP and MATN3 genesOk-Hwa Kim, Hyunwoong Park, Moon-Woo Seong, et al.
American Journal of Medical Genetics. Part A|May 13, 2017
Autosomal dominant frontometaphyseal dysplasia: Delineation of the clinical phenotypeEmma M Wade, Zandra A Jenkins, Philip B Daniel, et al.
Human Gene Therapy|May 3, 2022
Gene Therapy for Fibrodysplasia Ossificans Progressiva: Feasibility and ObstaclesElisabeth M W Eekhoff, Ruben D de Ruiter, Bernard J Smilde, et al.
JBMR Plus|October 27, 2025
Medical guidelines for fibrodysplasia ossificans progressivaFrederick S Kaplan, Mona Al Mukaddam, Genevieve Baujat, et al.
Pageof 25